Sign in

NCT06192121Completed

Web-Based Education for Individuals With Type-2 Diabetes

The Effect of Self-Care Disability Theory-Based Web-Based Education for Individuals With Type-2 Diabetes on Care Outcomes

Source: ClinicalTrials.gov · Last updated 24 Jul 2024

Brief summary (registry, in English)

Type and Aim of Research This research will be conducted as a randomised controlled experimental study design to test the effect of web-based diabetes education on the quality of life and self-care activities of individuals with Type 2 Diabetes. Place and Time of the Study This research will be conducted between September 2023 and March 2024 with individuals registered to the Cyprus Turkish Diabetes Association. Population and Sample of the Study The population of the study consisted of individuals with Type-2 diabetes who applied to the Cyprus Turkish Diabetes Centre. The sample of the study included individuals with type-2 diabetes who met the inclusion criteria at the Turkish Cypriot Diabetes Centre. Sample size was calculated using G Power statistical programme (n=74). In order to evaluate the effectiveness in the experimental and control groups, simple randomisation was performed to ensure the similarity of the two groups. Randomisation was applied after the pre-tests. The data of the study will be collected by Sociodemographic Data Form, Diabetes Specific Quality of Life Scale, Diabetes Self-Care Activities Questionnaire, Website Analysis and Measurement Inventory. The forms will be applied to the participants face to face. People in the experimental group, whose information was sent to the researcher, will receive reminder messages twice a week (Wednesday-Friday) during the 3-month follow-up period via the website. No intervention will be applied to the control group. The post-test will be applied.

Status (registry)
Completed
Study type
Interventional
Enrollment
80 (actual)
First submitted
20 Dec 2023
Start date
1 Sept 2023
Primary completion date
1 Mar 2024
Lead sponsor
Near East University, Turkey
NCT number
NCT06192121

What you commit to

  • Study type: Interventional
  • Participants enrolled: 80
  • From 1 Sept 2023 to the primary completion date, 1 Mar 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Working in the field of health and receiving health education in any field,

Other illness

  • Those with Type 1 Diabetes

Age

  • Under 18 years of age,

Other

  • Cannot use a computer or smartphone,
  • Individuals who participated in the preliminary application were not included in the study.

Who the study is looking for

  • Having access to the Internet,
  • Diagnosed with Type II Diabetes,
  • Mentally competent,
  • Individuals who volunteered to participate in the study were recruited.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Near East University
Coordinator of this site? Confirm its status
MersinTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.